Page 14 - UNION PROPERTIES GENERAL REPORT - FEBRUARY 2025

2/20/25, 10:56 AM 3 Promising Penny Stocks With Market Caps Over US$50M - Simply Wall St News
Kintor Pharmaceutical, a clinical-stage biotech firm, remains pre-revenue with less than US$1
million in revenue. The company recently completed the first subject enrollment for its Phase III
trial of KX-826 tincture for treating male androgenetic alopecia in China. Despite not having
meaningful revenue, Kintor has more cash than debt and covers both short-term and long-term

liabilities with its assets. However, it faces challenges with a limited cash runway and increasing
losses over five years at 22.2% annually. The board's experience is notable, but management
tenure data is insufficient to assess expertise fully.

Click here and access our complete financial health analysis report to understand the

dynamics of Kintor Pharmaceutical.
Review our historical performance report to gain insights into Kintor Pharmaceutical's track

record.

SEHK:9939 Debt to Equity History and Analysis as at Feb 2025

Zhejiang Reclaim Construction Group (SZSE:002586)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Zhejiang Reclaim Construction Group Co., Ltd. operates in the construction industry
and has a market cap of approximately CN¥2.39 billion.

https://simplywall.st/stocks/ae/real-estate-management-and-development/dfm-upp/union-properties-shares/news/3-promising-penny-stocks-with-mar… 4/10